These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 30901834)

  • 1. Impact of ERK5 on the Hallmarks of Cancer.
    Stecca B; Rovida E
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERK5 and its role in tumour development.
    Lochhead PA; Gilley R; Cook SJ
    Biochem Soc Trans; 2012 Feb; 40(1):251-6. PubMed ID: 22260700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.
    Simões AE; Rodrigues CM; Borralho PM
    Drug Discov Today; 2016 Oct; 21(10):1654-1663. PubMed ID: 27320690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERK5 and the regulation of endothelial cell function.
    Roberts OL; Holmes K; Müller J; Cross DA; Cross MJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1254-9. PubMed ID: 19909257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Avenues for Cancer Treatment: The MEK5-ERK5 Signaling Pathway.
    Pereira DM; Rodrigues CMP
    Trends Mol Med; 2020 Apr; 26(4):394-407. PubMed ID: 32277933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy.
    Tubita A; Lombardi Z; Tusa I; Dello Sbarba P; Rovida E
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular signal-regulated kinase 5 increases radioresistance of lung cancer cells by enhancing the DNA damage response.
    Jiang W; Jin G; Cai F; Chen X; Cao N; Zhang X; Liu J; Chen F; Wang F; Dong W; Zhuang H; Hua ZC
    Exp Mol Med; 2019 Feb; 51(2):1-20. PubMed ID: 30804322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK5: structure, regulation and function.
    Nithianandarajah-Jones GN; Wilm B; Goldring CE; Müller J; Cross MJ
    Cell Signal; 2012 Nov; 24(11):2187-96. PubMed ID: 22800864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic signaling of MEK5-ERK5.
    Hoang VT; Yan TJ; Cavanaugh JE; Flaherty PT; Beckman BS; Burow ME
    Cancer Lett; 2017 Apr; 392():51-59. PubMed ID: 28153789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling.
    Mansour MA; Hyodo T; Ito S; Kurita K; Kokuryo T; Uehara K; Nagino M; Takahashi M; Hamaguchi M; Senga T
    FEBS J; 2015 Apr; 282(8):1394-405. PubMed ID: 25662172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms of Epithelial to Mesenchymal Transition Regulated by ERK5 Signaling.
    Bhatt AB; Patel S; Matossian MD; Ucar DA; Miele L; Burow ME; Flaherty PT; Cavanaugh JE
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33572742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
    Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
    Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERK5 signalling in prostate cancer promotes an invasive phenotype.
    Ramsay AK; McCracken SR; Soofi M; Fleming J; Yu AX; Ahmad I; Morland R; Machesky L; Nixon C; Edwards DR; Nuttall RK; Seywright M; Marquez R; Keller E; Leung HY
    Br J Cancer; 2011 Feb; 104(4):664-72. PubMed ID: 21266977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton.
    Barros JC; Marshall CJ
    J Cell Sci; 2005 Apr; 118(Pt 8):1663-71. PubMed ID: 15797923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the BMK1 MAP kinase pathway in cancer therapy.
    Yang Q; Lee JD
    Clin Cancer Res; 2011 Jun; 17(11):3527-32. PubMed ID: 21385929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular signal regulated kinase 5 promotes cell migration, invasion and lung metastasis in a FAK-dependent manner.
    Jiang W; Cai F; Xu H; Lu Y; Chen J; Liu J; Cao N; Zhang X; Chen X; Huang Q; Zhuang H; Hua ZC
    Protein Cell; 2020 Nov; 11(11):825-845. PubMed ID: 32144580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.
    Simões AE; Pereira DM; Gomes SE; Brito H; Carvalho T; French A; Castro RE; Steer CJ; Thibodeau SN; Rodrigues CM; Borralho PM
    Cell Death Dis; 2015 Apr; 6(4):e1718. PubMed ID: 25855966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
    Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
    Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects.
    Dwivedi Y; Rizavi HS; Teppen T; Sasaki N; Chen H; Zhang H; Roberts RC; Conley RR; Pandey GN
    Neuropsychopharmacology; 2007 Nov; 32(11):2338-50. PubMed ID: 17342168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MEK5-ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer.
    Cristea S; Coles GL; Hornburg D; Gershkovitz M; Arand J; Cao S; Sen T; Williamson SC; Kim JW; Drainas AP; He A; Cam LL; Byers LA; Snyder MP; Contrepois K; Sage J
    Cancer Res; 2020 Mar; 80(6):1293-1303. PubMed ID: 31969375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.